<DOC>
	<DOCNO>NCT01222442</DOCNO>
	<brief_summary>The purpose research study evaluate effect AZD3199 electrical activity heart . The effect AZD3199 compare license antibiotic ( moxifloxacin ) . Moxifloxacin effect electrical activity heart well know . Safety tolerability AZD3199 much AZD3199 enters blood circulation also assess .</brief_summary>
	<brief_title>To Evaluate Effect AZD3199 Electrical Activity Heart</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>AZD-3199</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Healthy male subject age 18 45 year ( inclusive ) Have body mass index ( BMI ) 19 30 kg/m2 body weight 60 100 kg . Be nonsmoker exsmoker stop smoke ( use nicotine product ) &gt; 6 month prior study start . Be able inhale Turbuhaler inhaler accord give instruction . Any clinically significant disease disorder Any clinically relevant abnormal finding screen examination History additional risk factor Torsade de Pointes ( eg , heart failure , hypokalaemia , family history long QT syndrome ) . Any clinically important abnormality rhythm , conduction morphology rest ECG may interfere interpretation QTc interval change .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Respiratory disease</keyword>
	<keyword>Bronchiolitis</keyword>
	<keyword>Emphysema</keyword>
	<keyword>Lung disease cause persistent narrowing airway</keyword>
</DOC>